Ms. Maria M Rodriguez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Eugenio Maria De Hostos Ave # 345, Mayaguez, PR 00680 Phone: 787-265-8840 Fax: 787-265-8825 |
Mrs. Carmen Lugo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Ave Hostos, Mayaguez, PR 00680 Phone: 787-464-7124 Fax: 787-265-1074 |
Norma Santiago Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2031 Urbanizacion Colinas De Alturas, Mayaguez, PR 00680 Phone: 787-239-4600 |
Jose Rafael Lugo Toro Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 Calle Dr Ramon E Betances N, Mayaguez, PR 00680 Phone: 787-832-4200 |
Jennyliz Muniz Esteves, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Bo El Quemado Carr 106 Km 5 8, Mayaguez, PR 00680 Phone: 787-832-6074 |
Mrs. Ines Sanchez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 345 Hostos Avenue, Mayaguez, PR 00680 Phone: 787-834-6900 Fax: 787-265-8825 |
Dr. Melinda Matos, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: Mayaguez Outpatient Clinic, Vha, 345 Hostos Ave, Mayaguez, PR 00680 Phone: 787-834-6900 Fax: 787-265-8825 |
Glamaris Rodriguez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2097 Ave Hostos, Mayaguez, PR 00682 Phone: 787-805-4805 |
Mr. Israel Hernandez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 58 Calle Pablo Casals, Mayaguez, PR 00680 Phone: 787-834-2120 |
News Archive
Esophagectomy is a standard treatment for resectable esophageal carcinoma but relatively few patients are cured. Combined neoadjuvant chemoradiotherapy (CRT) or adjuvant CRT with surgery may improve survival but there is concern about treatment morbidity and the best sequencing of CRT and surgery.
Researchers from the United States have found that public may be under a mistaken belief regarding the efficacy of commercially available drugs and drug promotions and bias may be the reason behind this.
Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.
Two papers to be published in the Early Edition online of the Proceedings of the National Academy of Sciences (PNAS) the week of July 30-August 3, 2007 report findings that demonstrate that neuroprotectin D1 (NPD1) protects against damage to retinal pigment epithelial (RPE) cells and identifies an important trigger for its production and novel molecular mechanisms that support vision.
› Verified 7 days ago